Details for New Drug Application (NDA): 040572
✉ Email this page to a colleague
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 040572
| Tradename: | DEXAMETHASONE SODIUM PHOSPHATE |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | dexamethasone sodium phosphate |
| Patents: | 0 |
Pharmacology for NDA: 040572
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 040572
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 040572 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1391 | 51662-1391-1 | 10 mL in 1 VIAL (51662-1391-1) |
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 040572 | ANDA | Fresenius Kabi USA, LLC | 63323-516 | 63323-516-10 | 10 VIAL in 1 TRAY (63323-516-10) / 10 mL in 1 VIAL (63323-516-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG PHOSPHATE/ML | ||||
| Approval Date: | Apr 22, 2005 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
